Staging Gastric Cancer Patients after Complete Surgical Resection: Which System Should We Use?

被引：0
|
作者：
Sam S. Yoon
机构：
[1] Massachusetts General Hospital,Division of Surgical Oncology, Department of Surgery
[2] Harvard Medical School,undefined
来源：
Annals of Surgical Oncology | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2423 / 2425
页数：2
相关论文
共 50 条
  • [41] Which Electronic Health Record System Should We Use? A Systematic Review
    Al Ani, Mohammed
    Garas, George
    Hollingshead, James
    Cheetham, Drostan
    Athanasiou, Thanos
    Patel, Vanash
    MEDICAL PRINCIPLES AND PRACTICE, 2022, 31 (04) : 342 - 351
  • [42] Surveillance of Pancreatic Cancer Patients after Surgical Resection
    Kristin M. Sheffield
    Kristen T. Crowell
    Yu-Li Lin
    Clarisse Djukom
    James S. Goodwin
    Taylor S. Riall
    Annals of Surgical Oncology, 2012, 19 : 1670 - 1677
  • [43] Surveillance of Pancreatic Cancer Patients after Surgical Resection
    Sheffield, Kristin M.
    Crowell, Kristen T.
    Lin, Yu-Li
    Djukom, Clarisse
    Goodwin, James S.
    Riall, Taylor S.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (05) : 1670 - 1677
  • [44] Pretherapeutic Laparoscopic Paraaortic Staging in Advanced Cervical Cancer—Which Patients Should Be Considered?
    Michael Eichbaum
    Christof Sohn
    Annals of Surgical Oncology, 2011, 18 : 290 - 290
  • [45] HDR brachytherapy alone in the management of intermediate - High risk endometrial cancer patients after complete surgical staging
    Atahan, L.
    Ozyar, E.
    Genc, M.
    Kose, F.
    Ayhan, A.
    Kucukali, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S406 - S406
  • [46] A simplified and efficient modified TNM staging system for patients with gastric cancer after radical gastrectomy
    Huang Changming
    Lin Jianxian
    Hong Zhi-Liang
    Li Ping
    Tu Ruhong
    ANNALS OF ONCOLOGY, 2017, 28
  • [47] Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?
    C J Twelves
    J Cassidy
    British Journal of Cancer, 2002, 86 : 1670 - 1676
  • [48] Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?
    Twelves, CJ
    Cassidy, J
    BRITISH JOURNAL OF CANCER, 2002, 86 (11) : 1670 - 1676
  • [49] Which reference range should we use for transgender and gender diverse patients?
    Irwig, Michael S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (03): : E1479 - E1480
  • [50] Which antidiabetic agents should we use in diabetic patients with heart failure?
    不详
    DIABETES OBESITY & METABOLISM, 2008, 10 (01): : 98 - 98
12345